January 13, 2025 Experience GSK up to $1.15 billion acquisition of IDRx We are advising GSK on the transaction
January 13, 2025 Experience Landmark summary judgment decision for Meta and WhatsApp We secured a decision holding NSO Group liable for its 2019 spyware attack targeting WhatsApp and its users
January 13, 2025 Experience Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson We are advising Intra-Cellular Therapies on the transaction
January 10, 2025 Experience The Baldwin Group $935 million credit facilities financing We advised the borrower on the refinancing and amendment
January 10, 2025 Experience CRH $3 billion guaranteed notes offering The investment-grade notes are due 2030, 2035 and 2055
January 10, 2025 Experience iHeart comprehensive out-of-court debt restructuring We advised an ad hoc group of noteholders and term loan lenders on the transaction
January 10, 2025 Experience Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase We are advising Royalty Pharma on the transaction
January 10, 2025 Experience BrainAurora Medical Technology HK$583 million IPO We advised BrainAurora on its IPO and HKEX listing
January 8, 2025 Experience Veritas Technologies comprehensive debt recapitalization transaction We advised an ad hoc group of term lenders and noteholders on the transaction
January 8, 2025 Experience General Motors Financial $2.5 billion senior notes offering The investment-grade notes are due 2030 and 2035